The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam

Background: Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, because of their superior efficacy, excellent side...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Wellcome Open Res
Main Authors: Nguyen, Huyen Anh, Cooke, Graham S., Day, Jeremy N., Flower, Barnaby, Phuong, Le Thanh, Hung, Trinh Manh, Dung, Nguyen Thanh, Khoa, Dao Bach, Hung, Le Manh, Kestelyn, Evelyne, Thwaites, Guy E., Chau, Nguyen Van Vinh, Turner, Hugo C.
Formato: Artigo
Idioma:Inglês
Publicado em: F1000 Research Limited 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372532/
https://ncbi.nlm.nih.gov/pubmed/32734002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.15408.2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados